# US 2014/0155636 A1 · Process of separating chiral isomers of chroman compounds and their derivatives and precursors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0155636 A1
- Document ID: US20140155636A1
- Status: Published application
- Kind: A1
- Application number: 14/116,880
- Filed: 2012-05-08
- Published: 2014-06-05
- Earliest claimed: 2011-05-10
- Assignees: DSM IP Assetts B.V.
- Inventors: Gerhard Schiefer; Thomas Netscher; Alexander Lucia Leonardus Duchateau
- Web page: https://patentgrep.com/patent/US20140155636A1

## CPC

- C07D 311/04: Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07B 55/00: Racemisation; Complete or partial inversion
- C07B 57/00: Separation of optically-active compounds
- C07D 311/22: with oxygen or sulfur atoms directly attached in position 4
- C07D 311/72: 3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention relates to a process of separating chiral isomers of chroman compounds, particularly tocopherols and tocotrienols as well as the esters and intermediates thereof. It has been found that this process allows a separation of the desired isomer with a higher yield and enables the use of the non-desired isomers in a very efficient way. Said process is particularly useful when implemented in an industrial process. Furthermore, it has been found that this process allows using isomer mixtures as they result from traditional industrial synthesis.

## Claims

### Claim 1

Process of separating chiral isomers of formula (I-A) or (I-B) or (I-C)
wherein R1, R3 and R4 are independently from each other hydrogen or methyl groups;
R2 represents hydrogen or an phenol protection group;
R5 represents either a linear or branched completely saturated C6-25-alkyl group or a linear or branched C8-25-alkyl group comprising at least one carbon-carbon double bond;
and wherein * represents the chiral centre of the chiral isomer of formula (I-A) or (I-B) or (I-C);
comprising the steps
a) providing a mixture of at least two isomers of formula (I-A) or (I-B) or (I-C);
b) chromatographic separation of the mixture of isomers of formula (I-A) or (I-B) or (I-C) by means of a chiral phase into desired isomer (I) and residual (I′);
c) isomerizing the chirality at the centre indicated by * in formula (I-A) or (I-B) or (I-C) of the isomers of the residual (I′) being separated in step b);
d) adding the isomerized isomers obtained in step c) to a mixture of at least two isomers of formula (I-A) or (I-B) or (I-C) being object of further separation;
e) collecting the desired isomer (I).

### Claim 2 (depends on 1)

Process according to claim 1, characterized in that the isomerization in step c) takes place by exposure of the residual (I′) to a temperatures of above 150° C., particularly between 160 and 500° C., preferably between 160 and 300° C.

### Claim 3 (depends on 1)

Process according to claim 1, characterized in that the isomerization in step c) takes place by exposure of the residual (I′) to an acid of a pKa of smaller than 2, particularly smaller than 1.

### Claim 4 (depends on 3)

Process according to claim 3, characterized in that the acid having a pKa of smaller than 2 is p-toluenesulphonic acid.

### Claim 5 (depends on 1)

Process according to claim 1, characterized in that the isomerization in step c) takes place by exposure of the residual (I′) to a base of which the corresponding acid has a pKa of larger than 13.

### Claim 6 (depends on 1)

Process according to claim 1 characterized in that the process is a continuous process, particularly in that the mixture of at least two isomers of formula (I-A) or (I-B) or (I-C) being object of further separation is the mixture of at least two isomers of formula (I-A) or (I-B) or (I-C) of step a).

### Claim 7 (depends on 1)

Process according to claim 1 characterized in that R5 is of formula (II)
wherein m and p stand independently from each other for a value of 0 to 5 provided that the sum of m and p is 1 to 5,
and where the substructures in formula (II) represented by s1 and s2 can be in any sequence;
and the dotted line represents the bond by which the substituent of formula (II) is bound to the rest of formula (I-A) or (I-B) or (I-C).

### Claim 8 (depends on 1)

Process according to claim 1 characterized in that
R1═R3═R4═CH3
or
R1═R4═CH3,R3═H
or
R1═H,R3═R4═CH3
or
R1═R3═H,R4═CH3.

### Claim 9 (depends on 1)

Process according to claim 1 characterized in that R2 is H.

### Claim 10 (depends on 1)

Process according to claim 1 characterized in that the desired chiral isomers of formula (I-A) or (I-B) or (I-C) has the R-configuration at the carbon marked by * in formula (I-A) or (I-B) or (I-C).

### Claim 11 (depends on 1)

Process according to claim 1 characterized in that the desired chiral isomers of formula (I-A) or (I-B) or (I-C) are the isomers of a tocotrienol, particularly (2R)-tocotrienol, preferably (2R)-α-tocotrienol, or the acetate thereof.

### Claim 12 (depends on 1)

Process according to claim 1 characterized in that the desired chiral isomers of formula (I-A) or (I-B) or (I-C) are the isomers (2R,4′R,8′R)-α-tocopherol or (2R,4′R,8′R)-α-tocopheryl acetate.

### Claim 13 (depends on 1)

Process according to claim 1 characterized in that the desired chiral isomer is tocopherol or tocopheryl acetate obtained from tocotrienol, respectively tocotrienyl acetate, by a step of asymmetrical hydrogenation using a chiral iridium complex which takes place either before step b) or after step e).

### Claim 14 (depends on 1)

Process according to claim 1 characterized in that the chiral phase is a chiral phase of the group consisting of celluloses, amyloses, dextrans and cyclodextrines and their derivatives.

### Claim 15 (depends on 1)

Process according to claim 1 characterized in that the chiral chromatographic separation uses a Simulated Moving Bed (SMB) chromatography.

### Claim 16 (depends on 1)

Process according to claim 1 characterized in that the chromatographic separation in step b) is in presence of at least one alcohol, particularly in the presence of at least one alcohol which is selected from the group consisting of methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, isobutanol, tert.-butanol, 2-methyl-2-butanol, 3-methyl-2-butanol, 3-methyl-1-butanol, 2-methyl-1-butanol and allylalcohol, preferably 1-propanol.

### Claim 17 (depends on 1)

Process according to claim 1 characterized in that the chromatographic separation in step b) is in presence of at least an organic acid (S1) with a pKa of less than 6.0, particularly between 3.0 and 6.0, preferably to acetic acid.

### Claim 18 (depends on 1)

Food or feed or beverage comprising the desired chiral isomer of formula (I-A) or (I-B) or (I-C) being separated by claim 1.

### Claim 19 (depends on 1)

Pharmaceutical composition comprising the desired chiral isomer of formula (I-A) or (I-B) or (I-C) being separated by claim 1.
